
AI Enhances Monoclonal Antibody Development for Viral Infections
AI accelerates monoclonal antibody design, aiding in the fight against viral infections like RSV and avian influenza. π¦ π
Discover the newest research about AI innovations in π§ͺ Drug Discovery.

AI accelerates monoclonal antibody design, aiding in the fight against viral infections like RSV and avian influenza. π¦ π

Fungal virulence factors dataset aids IBD antifungal drug discovery. 18,072 VFs identified; 390 potential VFs predicted. π¦ π

Technological advancements in antibody therapeutics: 144 FDA-approved drugs, $267B sales, and AI-driven discoveries. ππ

Children’s drug development: 32.7% tumor reduction via imaging data. Optimized pricing ensures accessibility and R&D efficiency. ππ

Siamese Neural Networks enhance SARS-CoV-2 antibody interaction analysis, achieving 90% accuracy in predicting stable complexes. π€π¬

New antibiotic enterololin targets inflammatory bowel disease, developed with AI insights. Promising treatment for Crohn’s patients. π¦ π

AI tools are aiding scientists in tracking disease origins and immune responses, enhancing treatment strategies. π§¬π

2024 SRB Meeting: Key Advances in Reproductive Biology ππ¬, Climate Impact, AI Ethics, and Inclusion in Science.

Revolutionary AI model enhances IgG screening for antiviral therapy, targeting SARS-CoV-2 variants with 1300+ sequences analyzed. π¦ π

Deep learning revolutionizes drug-target interaction prediction, enhancing efficiency in drug discovery. Key metrics and architectures explored. ππ€